Desentum
A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system.
Desentum has raised €22M across 3 funding rounds from 2 investors, most recently a round in Feb 2024. Based in Espoo, Finland; founded 2011; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€22M
€21,900,000
Funding rounds
3
Investors
2
distinct backers
Active since
2018-10
latest 2024-02
Funding by year
EUR raised per yearDesentum — funding by year — interactive chart.
Data table
| Desentum — funding by year | |
|---|---|
| 2018 | €1.9M |
| 2022 | €8.0M |
| 2024 | €12M |
Signals
High confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-02-20 | Other | €12M | Springvest Oy | View deal → |
| 2022-01-21 | Other | €8.0M | Springvest Oy | View deal → |
| 2018-10-01 | Grant | €1.9M | EU | View deal → |
Investors
2Related news
- Desentum Raises M€8 in Fundingfinsmes.com · 2022-01
- goodnewsfinland.com
- siliconcanals.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData